


Vaccines are central to the fight against any infectious disease, and it is no different for the behemoth that is tuberculosis (TB). Despite being treatable and curable, TB remains the world’s deadliest infectious disease. But we can change that. New TB vaccines may finally be within reach, addressing a longstanding gap in the immunization landscape. The century-old Bacille Calmette-Guérin (BCG) vaccine provides robust protection to infants but not adolescents and adults, the main drivers of the epidemic. Several vaccine candidates are in late-stage trials, with results possible as early as 2028. The speed of innovation must be matched with proactive preparation by governments, funders, developers, and communities to ensure vaccines reach people without delay.
The TB Vax Info Hub, from Treatment Action Group (TAG) and partners, brings together handpicked resources on the questions, evidence, and actions that matter most for preparing for an equitable rollout of new TB vaccines.

